Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Hinge Bio, Inc.

Hinge Bio, Inc.

Stage unknownBurlingame, CAonchillespharma.comBiotechnology

Onchilles Pharma is a global drug discovery and development company pioneering first-in-class cytotoxic therapies designed to selectively kill cancer cells while preserving and activating immune function.

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Dec 31, 2024
    Form D equity offering · $30.6M (form d sold) · 82 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Hinge Bio, Inc. filed Form D: $30,596,388 sold of $40,800,009, Biotechnology”
Investors on record
1 edges
People
2 officers, 4 directors
Timeline
1
  1. Jan 15, 2025
    Hinge Bio, Inc. filed Form D: $30,596,388 sold of $40,800,009, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company